Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
11/2005
11/03/2005DE102004018198A1 Sulfonamide Sulfonamides
11/03/2005DE102004017933A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005DE102004017930A1 Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel New alkyne compounds with MCH-antagonistic activity and pharmaceutical compositions containing them
11/03/2005DE102004017438A1 Hetaryloxy-substituierte Phenylaminopyrimidine Hetaryloxy-substituted Phenylaminopyrimidine
11/03/2005CA2565219A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
11/03/2005CA2564356A1 Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
11/03/2005CA2562812A1 Imidazopyridine compound
11/03/2005CA2562417A1 Piperidine derivatives as modulators of chemokine receptor ccr5
11/03/2005CA2561724A1 Azaindoles useful as inhibitors of rock and other protein kinases
11/03/2005CA2561281A1 Pharmaceutical composition comprising a salt of mirtazapine
11/03/2005CA2558755A1 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds
11/02/2005EP1590349A1 Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
11/02/2005EP1590348A1 Aryl / hetaryl substituted imidazoquinolines
11/02/2005EP1590338A2 Modulators of melanocortin receptor
11/02/2005EP1590334A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta
11/02/2005EP1590328A2 (2-carboxamido) (3-amino) thiophene compounds
11/02/2005EP1590326A2 Substituted alkyl amido piperidines
11/02/2005EP1590314A2 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them
11/02/2005EP1589969A2 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/02/2005EP1427415A4 Lactam-containing compounds and derivatives thereof as factor xa inhibitors
11/02/2005EP1292304B1 Zolpidem hemitartrate
11/02/2005EP1102767B1 Substituted pyrazole derivatives
11/02/2005EP0929520B1 Indolinone combinatorial libraries and related products and methods for the treatment of disease
11/02/2005CN1692115A Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
11/02/2005CN1692113A Polysubstituted imidazopyridines as gastric secretion inhibitors
11/02/2005CN1692112A Benzimidazole quinolinones and uses thereof
11/01/2005US6960662 Process for preparing 2-(4-pyridyl)amino-6-dialkyloxyphenyl-pyrido[2,3-d]pyrimidin-7-ones
11/01/2005US6960608 Fused indazoles and indoles and their use for the treatment of glaucoma
11/01/2005US6960603 Emzyme inhibitors, a 4-pyridinyl-3-pyrazoles derivatives, treating animal having cancer, restenosis, psoriasis, endometriosis, atherosclerosis, ischemia, myocardial ischemic; a plant having yeast infection and viral infection
11/01/2005US6960598 (1,8) naphthyridines as gaba ligands, their pharmaceutical compositions and uses
11/01/2005US6960595 5-6 to 5-7 Heterobicycles as factor Xa inhibitors
11/01/2005US6960591 Propane-1,3-dione derivative
11/01/2005US6960587 Piperido(1,2-a)piperazine-1,4-dione derivatives fused to a 5-7 membered ring at the 7-8 position; cGMP-specific PDE inhibitors; treatment of cardiovascular disorders and erectile dysfunction.
11/01/2005US6960585 For therapy of inflammatory and immune diseases
11/01/2005US6960474 Method for the treatment of a condition remediable by administration of a selective androgen receptor modulator
10/2005
10/27/2005WO2005101838A2 Piperazinylpiperidine derivatives as chemokine receptor antagonists
10/27/2005WO2005100360A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
10/27/2005WO2005100359A1 Composition containing a monomer compound exhibiting an optical property, method making use of said composition, a monomer compound and polymer containing said compound
10/27/2005WO2005100358A1 Fused ring nk1 antagonists
10/27/2005WO2005100357A1 Mitotic kinesin inhibitors
10/27/2005WO2005100356A1 Inhibitors of akt activity
10/27/2005WO2005100355A1 Cyclic amine compound
10/27/2005WO2005100354A1 Process for production of pyrazole-fused ring derivatives
10/27/2005WO2005100353A1 Condensed pyridine derivatives useful as a28 adenosine receptor antagonists
10/27/2005WO2005100352A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005WO2005100349A2 Polycyclic pyridines as potassium ion channel modulators
10/27/2005WO2005100343A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
10/27/2005WO2005100340A2 Polycyclic pyridines as potassium ion channel modulators
10/27/2005WO2005100334A1 Dipeptidyl peptidase-iv inhibitors
10/27/2005WO2005100305A1 Androgen modulators
10/27/2005WO2005100285A2 Novel alkyne compounds exhibiting an mch antagonistic effect and drugs containing said compounds
10/27/2005WO2005099696A1 Medicine comprising combination of acetylcholine esterase inhibitor and 5-substituted 3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative
10/27/2005WO2005099688A2 Cyclic compounds
10/27/2005WO2005074642A3 Chemical compounds
10/27/2005WO2005070932A3 Substituted heterocyclic compounds and methods of use
10/27/2005WO2004113275A3 Methods and compositions for treating amyloid-related diseases
10/27/2005WO2004089366A8 Bicyclic compounds as nr2b receptor antagonists
10/27/2005WO2004058704A8 Quinazolinones as potassium channel modulators
10/27/2005US20050240021 Fused heterobicyclo substituted phenyl metabotropic glutamate-5 modulators
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239855 For therapy of cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/27/2005US20050239823 2,7-dimethylimidazo[1,2- alpha ]pyridin-3-ylmethyl)-dimethylamine; nitric oxide synthase inhibitor; neurodegenerative diseases and antiinflammatory, antitumor agent; multiple sclerosis, Parkinson's, Alzheimer's or Huntington's disease, cerebral ischemia, diabetes, meningitis, angiogenesis,
10/27/2005US20050239822 Substituted C-imiadazol[1,2-a] pyridin-3-yl-methylamines
10/27/2005US20050239821 Viral inhibitors
10/27/2005US20050239820 1-(4-(4-Amino-1H-pyrrolo[3,2-c]pyridin-1-yl)phenyl)-3-(2-(4-fluorophenyl)acetyl)thiourea, hydrochloride salt; anticarcinogenic agents; modulators to impact angiogenesis-dependent diseases
10/27/2005US20050239819 4-Oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
10/27/2005US20050239816 Amonafide salts
10/27/2005US20050239815 Receptor or non-receptor; 5,6,7,8,9,10-hexahydro-6,9-(epiminomethano) benzo[ alpha ][8]annulenes; anticarcinogenic, antidiabetic, antiproliferative agents; autoimmune and Crohn's diseases, acromegaly, aging resistance; coadminister tamoxifen, raloxifene, taxol, trastuzumab, tirofiban or a COX-2 inhibitor
10/27/2005US20050239814 RSV polymerase inhibitors
10/27/2005US20050239797 Isoquinoline and quinazoline derivatives having a combined 5HT1A, 5HT1B, and 5HT1D receptor activity
10/27/2005US20050239791 Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
10/27/2005US20050239788 Substituted with pyrrolopiperazine; schizophrenia, psychosis, depression; inhibition of the 5-HT6 receptor
10/27/2005US20050239781 For therapy of inflammatory disease and cancer
10/27/2005US20050239780 Tetrahydropyran derivative
10/27/2005US20050239775 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression
10/27/2005US20050239774 Biaryl diazabicycloalkane amides as nicotinic acetylcholine agonists
10/27/2005US20050239773 1-[9-(3-Phenyl-allyl)-3,9 diaza-bicyclo[4.2.1]non-3-yl]-propan-1-one; analgesic; great selectivity to mu receptor; analgesic; pain relief, drug dependence, alcoholism; side effect reduction
10/27/2005US20050239771 Respiratory syncytial virus replication inhibitors
10/27/2005US20050239768 Trans-(4a,9b)-2-methyl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indol-6-yl-4-methylphenyl sulfide; 5-HT2 receptor modulation; schizophrenia, anxiety, depression, and migraines
10/27/2005US20050239107 Trapped photochromes and thermochromes and uses for chromogenic detection, including detection of airborne contaminants
10/27/2005US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds
10/27/2005US20050236980 Charge transport compositions and electronic devices made with such compounds
10/27/2005US20050236974 Condensed polycyclic compound and organic light-emitting device using the same
10/27/2005DE102004018795A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
10/27/2005DE102004018794A1 Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel Selected CGRP antagonists, processes for their preparation and their use as medicaments
10/27/2005CA2563386A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments
10/27/2005CA2563291A1 4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
10/27/2005CA2562694A1 Medicine comprising combination of acetylcholine esterase inhibitor and 5-substituted 3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative
10/27/2005CA2562578A1 Process for production of pyrazole-fused ring derivatives
10/27/2005CA2562529A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments
10/27/2005CA2562526A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs
10/27/2005CA2562406A1 Cyclic amine compound
10/27/2005CA2562369A1 Condensed pyridine derivatives useful as a28 adenosine receptor antagonists
10/27/2005CA2562244A1 Cyclic compounds
10/27/2005CA2562235A1 Piperazinylpiperidine derivatives as chemokine receptor antagonists
10/27/2005CA2562138A1 Fused ring nk1 antagonists
10/27/2005CA2561904A1 Mitotic kinesin inhibitors
10/27/2005CA2561718A1 Polycyclic pyridines as potassium ion channel modulators
10/27/2005CA2561315A1 Inhibitors of akt activity
10/27/2005CA2560346A1 Polycyclic pyridines as potassium ion channel modulators
1 ... 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 ... 646